The outer monolayer of animal plasma membranes is principally composed of choline-phospholipids while the amino-phospholipids reside in the inner monolayer. This anisotropic distribution is a steady state. The choline-lipids are submitted to a slow and passive transmembrane diffusion and the amino-lipids are inwardly transported by an ATP-dependent carrier, the amino-phospholipid translocase or 'flippase'. The transport system has been characterized functionally and recently associated in red cells with a 110-kDa Mg-ATPase. Experiments indicate that the translocase can maintain by itself the amino-lipid asymmetry without requiring the help of cytoskeletal proteins. In the endoplasmic reticulum, phospholipids experience a facilitated diffusion involving a non-ATP-dependent 'flippase'. A similar system exists in the liver canalicular plasma membrane. It has been demonstrated that the phosphatidylcholine secretion into the bile is under the control of the P-glycoprotein encoded by the mdr2 gene. The question arises whether the related protein from the mdr1 gene, which confers the multi-drug resistance to cells in which it is expressed, could also function as a lipid flippase. In response to some cellular events, such as blood platelet stimulation, the phospholipid asymmetry may suddenly collapse. The exact mechanism by which this randomization occurs is still unknown, but both a 'scramblase' protein and a minor lipid (PIP2) have been proposed as mediators of the event. Maintaining a plasma membrane asymmetry, even at the expense of energy consumption, is important for some cells: the appearance of phosphatidylserine into the outer membrane leaflet of blood cells generates a procoagulant surface catalysing the clot formation. It is also responsible for the recognition and phagocytosis of erythrocytes by macrophages. Finally, the amino-phospholipid translocase could play an important role in the control of membrane curvature, particularly in the initiation of vesicle formation.